John Garibotto is a distinguished veteran of the medical device industry with more than 25 years of experience. Throughout his career, he has led the development, formation, and financing of several successful medical device companies, including Insulet Corporation and TransVascular, Inc., which was acquired by Medtronic. Garibotto has also been instrumental in securing 39 patents with 30 additional published and pending applications, showcasing his impressive technical expertise.

At Securus Medical, Garibotto served as the founder and Chief Technology Officer responsible for leading the development of a cutting-edge infrared tissue temperature monitoring and mapping system, which offered cardiac catheter ablation procedures for atrial fibrillation. The company was later acquired by Boston Scientific, a testament to Garibotto's ability to identify high-potential medical device applications and deliver exceptional results.

As the Co-Founder and Vice President of Research, Development, and Engineering at Insulet Corp., Garibotto spearheaded the development and commercialization of the world's first wireless, disposable, body-worn diabetes management system- Omnipod. The system won several awards, including the renowned Edison Award for Best New Product in 2009.

Garibotto's exceptional leadership and management skills extend beyond product development. He has led the transfer of products to China and the outsourcing of development resources to India. He earned a B.S. in Industrial Technology from the University of Massachusetts at Lowell and a Master's in Business Administration from Northeastern University.

In summary, John Garibotto is one of the eminent figures in the medical device industry, with a proven record of leadership, technical expertise, and business acumen. He has built successful medical device companies, secured numerous patents, and spearheaded the development of high-tech medical devices, showcasing his talent in the healthcare sector.